본문 바로가기
KERD
논문KCI 등재

Role of Ghrelin in the Pathophysiology of Gastrointestinal Disease

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Ghrelin is a 28-amino-acid peptide that plays multiple roles in humans and other mammals. The functions of ghrelin include food intake regulation, gastrointestinal (GI) motility, and acid secretion by the GI tract. Many GI disorders involving infection, inflammation, and malignancy are also correlated with altered ghrelin production and secretion. Although suppressed ghrelin responses have already been observed in various GI disorders, such as chronic gastritis, Helicobacter pylori infection, irritable bowel syndrome, functional dyspepsia,and cachexia, elevated ghrelin responses have also been reported in celiac disease and inflammatory bowel disease. Moreover, we recently reported that decreased fasting and postprandial ghrelin levels were observed in female patients with functional dyspepsia compared with healthy subjects. These alterations of ghrelin responses were significantly correlated with meal-related symptoms (bloating and early satiation)in female functional dyspepsia patients. We therefore support the notion that abnormal ghrelin responses may play important roles in various GI disorders. Furthermore, human clinical trials and animal studies involving the administration of ghrelin or its receptor agonists have shown promising improvements in gastroparesis, anorexia, and cancer. This review summarizes the impact of ghrelin, its family of peptides,and its receptors on GI diseases and proposes ghrelin modulation as a potential therapy

Abstract

Ghrelin is a 28-amino-acid peptide that plays multiple roles in humans and other mammals. The functions of ghrelin include food intake regulation, gastrointestinal (GI) motility, and acid secretion by the GI tract. Many GI disorders involving infection, inflammation, and malignancy are also correlated with altered ghrelin production and secretion. Although suppressed ghrelin responses have already been observed in various GI disorders, such as chronic gastritis, Helicobacter pylori infection, irritable bowel syndrome, functional dyspepsia,and cachexia, elevated ghrelin responses have also been reported in celiac disease and inflammatory bowel disease. Moreover, we recently reported that decreased fasting and postprandial ghrelin levels were observed in female patients with functional dyspepsia compared with healthy subjects. These alterations of ghrelin responses were significantly correlated with meal-related symptoms (bloating and early satiation)in female functional dyspepsia patients. We therefore support the notion that abnormal ghrelin responses may play important roles in various GI disorders. Furthermore, human clinical trials and animal studies involving the administration of ghrelin or its receptor agonists have shown promising improvements in gastroparesis, anorexia, and cancer. This review summarizes the impact of ghrelin, its family of peptides,and its receptors on GI diseases and proposes ghrelin modulation as a potential therapy

참고문헌 (82)

  1. Akila De Silva, "Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity", Gut and Liver, 6(1), pp.10~20 (2012), 거트앤리버 발행위원회
  2. Kojima M, "Clinical endocrinology and metabolism. Ghrelin, a novel growth-hormone-releasing and appetite-stimulating peptide from stomach", Best Pract Res Clin Endocrinol Metab, 18, pp.517~530 (2004)
  3. Sato T, "Structure, regulation and function of ghrelin", J Biochem, 151, pp.119~128 (2012)
  4. Hosoda H, "Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing", J Biol Chem, 278, pp.64~70 (2003)
  5. Arvat E, "Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans", J Endocrinol Invest, 23, pp.493~495 (2000)
  6. Tschop M, "Ghrelin induces adiposity in rodents", Nature, 407, pp.908~913 (2000)
  7. Masuda Y, "Ghrelin stimulates gastric acid secretion and motility in rats", Biochem Biophys Res Commun, 276, pp.905~908 (2000)
  8. Tack J, "Influence of ghrelin on interdigestive gastrointestinal motility in humans", Gut, 55, pp.327~333 (2006)
  9. Nakazato M, "A role for ghrelin in the central regulation of feeding", Nature, 409, pp.194~198 (2001)
  10. Cummings DE, "A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans", Diabetes, 50, pp.1714~1719 (2001)
  11. Tschop M, "Post-prandial decrease of circulating human ghrelin levels", J Endocrinol Invest, 24, pp.RC19~RC21 (2001)
  12. Callahan HS, "Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans", J Clin Endocrinol Metab, 89, pp.1319~1324 (2004)
  13. Kojima M, "Structure and function of ghrelin", Results Probl Cell Differ, 46, pp.89~115 (2008)
  14. Fujino K, "Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats", J Physiol, 550(Pt 1), pp.227~240 (2003)
  15. Yang J, "Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone", Cell, 132, pp.387~396 (2008)
  16. Monteleone P, "Plasma obestatin, ghrelin, and ghrelin", obestatin ratio are increased in underweight patients with anorexia nervosa but not in symptomatic patients with bulimia nervosa, 2008, pp.93, 4418~4421
  17. Garcia JM, "Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia", J Clin Endocrinol Metab, 90, pp.2920~2926 (2005)
  18. DelParigi A, "High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome", J Clin Endocrinol Metab, 87, pp.5461~5464 (2002)
  19. Cheung CK, "Decreased basal and postprandial plasma acylated Ghrelin in female patients with functional dyspepsia (FD)", Gastroenterology, 142(5 Suppl 1), pp.S~170 (2012)
  20. Hosoda H, "Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue", Biochem Biophys Res Commun, 279, pp.909~913 (2000)
  21. Kojima M, "Ghrelin is a growth-hormone-releasing acylated peptide from stomach", Nature, 402, pp.656~660 (1999)
  22. Stengel A, "The RAPID method for blood processing yields new insight in plasma concentrations and molecular forms of circulating gut peptides", Endocrinology, 150, pp.5113~5118 (2009)
  23. Hosoda H, "Purification and characterization of rat des-Gln14-Ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor", J Biol Chem, 275, pp.21995~22000 (2000)
  24. Nogueiras R, "Ghrelin: new molecular pathways modulating appetite and adiposity", Obes Fact, 3, pp.285~292 (2010)
  25. Chen CY, "Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats", Gastroenterology, 129, pp.8~25 (2005)
  26. Inhoff T, "Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats", Peptides, 29, pp.2159~2168 (2008)
  27. Zhang JV, "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake", Science, 310, pp.996~999 (2005)
  28. Chartrel N, "Comment on “obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake”", Science, 315, pp.766~ (2007)
  29. Sjolund K, "Covariation of plasma ghrelin and motilin in irritable bowel syndrome", Peptides, 31, pp.1109~1112 (2010)
  30. Zhang N, "Meta-analysis of the relationship between obestatin and ghrelin levels and the ghrelin", obestatin ratio with respect to obesity, 2011, pp.341, 48~55
  31. Harsch IA, "Ghrelin and obestatin levels in type 2 diabetic patients with and without delayed gastric emptying", Dig Dis Sci, 54, pp.2161~2166 (2009)
  32. Brown JC, "The further purification of motilin, a gastric motor activity stimulating polypeptide from the mucosa of the small intestine of hogs", Can J Physiol Pharmacol, 49, pp.399~405 (1971)
  33. Helmstaedter V, "Immunohistochemical localization of motilin in endocrine non-enterochromaffin cells of the small intestine of humans and monkey", Gastroenterology, 76(5 Pt 1), pp.897~902 (1979)
  34. Ruppin H, "Demling L. Effects of 13-nle-motilin in man: inhibition of gastric evacuation and stimulation of pepsin secretion", Scand J Gastroenterol, 10, pp.199~202 (1975)
  35. Christofides ND, "Effect of motilin on the gastric emptying of glucose and fat in humans", Gastroenterology, 80, pp.456~460 (1981)
  36. Gutierrez JA, "Ghrelin octanoylation mediated by an orphan lipid transferase", Proc Natl Acad Sci U S A, 105, pp.6320~6325 (2008)
  37. Zhao TJ, "Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice", Proc Natl Acad Sci U S A, 107, pp.7467~7472 (2010)
  38. Howard AD, "A receptor in pituitary and hypothalamus that functions in growth hormone release", Science, 273, pp.974~977 (1996)
  39. Sun Y, "Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor", Proc Natl Acad Sci U S A, 101, pp.4679~4684 (2004)
  40. Zigman JM, "Mice lacking ghrelin receptors resist the development of diet-induced obesity", J Clin Invest, 115, pp.3564~3572 (2005)
  41. Checchi S, "Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies", J Clin Endocrinol Metab, 92, pp.4346~4351 (2007)
  42. Marshall BJ., "The Campylobacter pylori story", Scand J Gastroenterol Suppl, 146, pp.58~66 (1988)
  43. Uemura N, "Helicobacter pylori infection and the development of gastric cancer", N Engl J Med, 345, pp.784~789 (2001)
  44. Tatsuguchi A, "Effect of Helicobacter pylori infection on ghrelin expression in human gastric mucosa", Am J Gastroenterol, 99, pp.2121~2127 (2004)
  45. Isomoto H, "Low plasma ghrelin levels in patients with Helicobacter pylori-associated gastritis", Am J Med, 117, pp.429~432 (2004)
  46. Jang EJ, "The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease", JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 23(23 Suppl 2), pp.S278~S285 (2008), BLACKWELL PUBLISHING
  47. Papotti M, "Ghrelin-producing endocrine tumors of the stomach and intestine", J Clin Endocrinol Metab, 86, pp.5052~5059 (2001)
  48. Volante M, "Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors", J Clin Endocrinol Metab, 87, pp.1300~1308 (2002)
  49. Mottershead M, "Immunohistochemical and quantitative mRNA assessment of ghrelin expression in gastric and oesophageal adenocarcinoma", J Clin Pathol, 60, pp.405~409 (2007)
  50. Huang Q, "Circulating ghrelin in patients with gastric or colorectal cancer", Dig Dis Sci, 52, pp.803~809 (2007)
  51. "Clinical significance of ghrelin concentration of plasma and tumor tissue in patients with gastric cancer", JOURNAL OF SURGICAL RESEARCH, 143, pp.344~349 (2007), ACADEMIC PRESS INC ELSEVIER SCIENCE
  52. Waseem T, "Role of ghrelin axis in colorectal cancer: a novel association", Peptides, 29, pp.1369~1376 (2008)
  53. Edholm T, "Ghrelin stimulates motility in the small intestine of rats through intrinsic cholinergic neurons", Regul Pept, 121, pp.25~30 (2004)
  54. Trudel L, "Ghrelin", motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat, 2002, pp.282, G948~G952
  55. Greenwood-Van Meerveld B, "Ghrelin as a target for gastrointestinal motility disorders", Peptides, 32, pp.2352~2356 (2011)
  56. Ariga H, "Ghrelin accelerates gastric emptying via early manifestation of antro-pyloric coordination in conscious rats", Regul Pept, 146, pp.112~116 (2008)
  57. Zheng J, "Ghrelin regulates gastric phase III-like contractions in freely moving conscious mice", Neurogastroenterol Motil, 21, pp.78~84 (2009)
  58. Taniguchi H, "Effects of ghrelin on interdigestive contractions of the rat gastrointestinal tract", World J Gastroenterol, 14, pp.6299~6302 (2008)
  59. Ohno T, "Ghrelin does not stimulate gastrointestinal motility and gastric emptying: an experimental study of conscious dogs", Neurogastroenterol Motil, 18, pp.129~135 (2006)
  60. Fujimiya M, "Regulation of gastroduodenal motility: acyl ghrelin, des-acyl ghrelin and obestatin and hypothalamic peptides", Digestion, 85, pp.90~94 (2012)
  61. Cummings DE, "Elevated plasma ghrelin levels in Prader Willi syndrome", Nat Med, 8, pp.643~644 (2002)
  62. Uday C Ghoshal, "Epidemiology of Uninvestigated and Functional Dyspepsia in Asia: Facts and Fiction", Journal of Neurogastroenterology and Motility (JNM), 17(3), pp.235~244 (2011), 대한소화기 기능성질환∙운동학회
  63. Tack J, "Functional gastroduodenal disorders", Gastroenterology, 130, pp.1466~1479 (2006)
  64. Lee KJ, "Plasma ghrelin levels and their relationship with gastric emptying in patients with dysmotility-like functional dyspepsia", Digestion, 80, pp.58~63 (2009)
  65. Shindo T, "Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease", Digestion, 79, pp.65~72 (2009)
  66. Lanzini A, "Circulating ghrelin level is increased in coeliac disease as in functional dyspepsia and reverts to normal during gluten-free diet", Aliment Pharmacol Ther, 23, pp.907~913 (2006)
  67. Capristo E, "Reduced plasma ghrelin concentration in celiac disease after gluten-free diet treatment", Scand J Gastroenterol, 40, pp.430~436 (2005)
  68. Gwee KA, "The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community", Am J Gastroenterol, 99, pp.924~931 (2004)
  69. Longstreth GF, "Functional bowel disorders", Gastroenterology, 130, pp.1480~1491 (2006)
  70. Van Der Veek PP, "Proximal and distal gut hormone secretion in irritable bowel syndrome", Scand J Gastroenterol, 41, pp.170~177 (2006)
  71. Simren M, "High interdigestive and postprandial motilin levels in patients with the irritable bowel syndrome", Neurogastroenterol Motil, 17, pp.51~57 (2005)
  72. El-Salhy M, "Ghrelin in patients with irritable bowel syndrome", Int J Mol Med, 23, pp.703~707 (2009)
  73. Karmiris K, "Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease", Inflamm Bowel Dis, 12, pp.100~105 (2006)
  74. Ates Y, "Serum ghrelin levels in inflammatory bowel disease with relation to disease activity and nutritional status", Dig Dis Sci, 53, pp.2215~2221 (2008)
  75. Hosomi S, "Phenotypical and functional study of ghrelin and its receptor in the pathogenesis of Crohn’s disease", Inflamm Bowel Dis, 14, pp.1205~1213 (2008)
  76. Trudel L, "Two new peptides to improve post-operative gastric ileus in dog", Peptides, 24, pp.531~534 (2003)
  77. Tack J, "Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis", Aliment Pharmacol Ther, 22, pp.847~853 (2005)
  78. Ejskjaer N, "Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study", Neurogastroenterol Motil, 22, pp.1069~e1281 (2010)
  79. Hanada T, "Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells", Biochem Biophys Res Commun, 301, pp.275~279 (2003)
  80. Takiguchi S, "Effect of rikkunshito, a Japanese herbal medicine, on gastrointestinal symptoms and ghrelin levels in gastric cancer patients after gastrectomy", Gastric Cancer, 16, pp.167~174 (2013)
  81. Takeda H, "Rikkunshito and ghrelin secretion", Curr Pharm Des, 18, pp.4827~4838 (2012)
  82. Gonzalez-Rey E, "Therapeutic action of ghrelin in a mouse model of colitis", Gastroenterology, 130, pp.1707~1720 (2006)

관련 논문AI추천

이 간행물의 다른 논문 (18건)